AVTX
Avalo Therapeutics, Inc.Pre-market12.01−1.23 −9.29%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delayPre-market 12.02 +0.08%
Open
13.23
Prev close
13.24
Day range
11.9913.23
52-week range
11.9924.27
Volume
1.65M1.79×
Mkt cap
644.10M
P/E ttm
—
Fwd P/E
-4.43
EPS ttm
-4.31
Div yield
0.00%
Earnings
Aug 6, 2026
From 52w high
−50.52%
AVTX earnings and estimates
AVTX Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 12
Before the open · estimated
EPS consensus
$−0.56
range −0.66 – −0.45
EPS growth vs year ago
+74.3%
year ago −2.19
Revenue consensus
$0
0.0% vs year ago
Options-implied move
±45.8%
by Nov 20 · ATM straddle
Past 4 reactions
±2.0%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 6, 2026 BMO | −0.83 | −0.62 | −34.52% | $0 | −0.7% | +3.8% |
| Mar '26 | May 13, 2026 BMO | −0.98 | −1.07 | +8.55% | $0 | −0.5% | −18.4% |
| Dec '25 | Mar 23, 2026 BMO | −0.37 | −1.50 | +75.25% | $59.00K | +0.6% | +3.5% |
| Sep '25 | Nov 6, 2025 BMO | −2.19 | −1.64 | −33.70% | $0 | −6.3% | −6.2% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.56 | −0.66−0.45 | +74.3% | $0 | 0.0% | −0.56 −0.4% | −0.55 −2.1% | 3 / 2 |
| Next quarter Dec 2026 | −0.52 | −0.70−0.39 | −40.9% | $0 | −100.0% | −0.51 −1.6% | −0.66 +20.7% | 3 / 2 |
| Current year Dec 2026 | −2.73 | −3.06−2.18 | +53.3% | $0 | −100.0% | −2.72 −0.2% | −2.56 −6.7% | 3 / 4 |
| Next year Dec 2027 | −2.71 | −4.10−1.33 | +0.7% | $0 | 0.0% | −2.74 +1.2% | −2.76 +2.0% | 3 / 4 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.63 | −0.86−0.45 | 5 | 0 / 0 |
| Dec 2026 | −0.65 | −0.89−0.43 | 4 | 0 / 0 |
| Mar 2027 | −0.68 | −0.96−0.49 | 3 | 0 / 0 |
| Jun 2027 | −0.74 | −1.08−0.55 | 3 | 0 / 0 |
| Sep 2027 | −0.79 | −1.17−0.59 | 3 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −2.80 | −3.56−2.07 | 6 | 0 / 0 |
| Dec 2027 | −2.87 | −4.10−2.26 | 6 | 0 / 0 |
| Dec 2028 | −2.72 | −3.44−2.00 | 2 | 0 / 0 |
| Dec 2029 | −2.67 | −3.56−1.79 | 2 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.